Balsm Alofoq Medical Co. (9620) is listed on Nomu of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2024, Balsm Alofoq Medical Co. reported revenue of SAR 20M, net profit of SAR 5M, and earnings per share of SAR 4.68. Total assets stood at SAR 33M with total equity of SAR 29M and total liabilities of SAR 4M.

Operating cash flow for 2024 was SAR 5M, representing a cash conversion ratio of 1.15 relative to net profit. Free cash flow was SAR 5M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2024, SAR 1.15 arrived as operating cash. This indicates Exceptional quality earnings based on the cash conversion ratio of 1.15.

Key financial ratios for 2024: Return on Equity 16.5%, Return on Assets 14.4%, Net Margin 24.1%, Debt to Equity 0.15.